Skip to main content
Bismarck Christian Odei
( out of 45 reviews )

Bismarck Christian Odei, MD

Languages spoken: English, Spanish

Clinical Locations

  • Dr Bismarck Odei is a physician-scientist and an Assistant Professor in Genitourinary Cancers at the Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah. He completed his undergraduate degree in Chemical Engineering at Brigham Young University. He subsequently completed his medical training at UCLA School of Medicine in Los Angeles, California. He was a resident and chief resident at The Ohio State Department of Radiation Oncology.

    Dr Odei's is passionate about the success of his patients, and he is committed to attentive patient care, effective patient education, and implementation of safe and cutting-edge technology to improve patient outcomes.

    Dr Odei's research interests include optimization of genitourinary cancer treatments, understanding the role of radiotherapy and hormone therapy in recurrent or metastatic prostate cancer, incorporating biomarker use for prognostication and predictive evaluation in prostate/bladder cancers, and the utilization of artificial intelligence for synthesizing molecular signatures to inform clinic management decisions. His non-cancer related research work focuses on equity in the academic workforce and health equity.

    Dr Odei's work has been published in premier medical journals such as JAMA Internal Medicine, JAMA Network Open, and International Journal of Radiation Oncology, Biology, and Physics. He has presented his research at international conferences such as the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), and National Medical Association (NMA). Some of his research work has scored in the top 5% of all research outputs scored by Altmetric.

    He is the recent recipient of the 2023 University of Utah GUCC Pilot Grant for prostate cancer research, and the highly-competitive Robert A. Winn Diversity in Clinical Trials: Career Development Award, supported by the Bristol Myers Squibb Foundation.

    Outside of work he enjoys spending time with his wife and daughters, playing chess, and volunteers in religious and community events.

    Patient Rating

    5.0 /5
    ( out of 45 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 20, 2023
    HUNTSMAN CANCER CENTER

    He is the best! He is really concerned about giving the best care possible!

    September 16, 2023
    FARMINGTON HEALTH CENTER

    Dr. Bismarck Christian Larbi Odei is amazing , and knowledgeable, and empathetic and...

    September 10, 2023
    HUNTSMAN CANCER CENTER

    Dr Bismarck was very efficient and fun to work with.

    August 13, 2023
    HUNTSMAN CANCER CENTER

    Kind, compassionate, clear, caring, knowledgeable, all around great!

    June 18, 2023
    HUNTSMAN CANCER CENTER

    Took time to concentrate on my case.

    June 14, 2023
    HUNTSMAN CANCER CENTER

    Dr Odei is the perfect combination of professional and personable. Hes taken time to connect with me beyond just treatment and I feel well cared for through my radiation treatment. And I feel hes cheering for my full recovery.

    April 27, 2023
    HUNTSMAN CANCER CENTER

    An XCLNT (Excellent) Service (O_O) Highly Recommended (*_*)

    April 12, 2023
    HUNTSMAN CANCER CENTER

    Thorough Doctor, asking all the correct anwsers and listening, not just hearing.

    April 11, 2023
    HUNTSMAN CANCER CENTER

    Dr Odei was very helpful and friendly explaining the treatment options and helping me decide on the right one.

  • Dr Bismarck Odei is a physician-scientist and an Assistant Professor in Genitourinary Cancers at the Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah. He completed his undergraduate degree in Chemical Engineering at Brigham Young University. He subsequently completed his medical training at UCLA School of Medicine in Los Angeles, California. He was a resident and chief resident at The Ohio State Department of Radiation Oncology.

    Dr Odei's is passionate about the success of his patients, and he is committed to attentive patient care, effective patient education, and implementation of safe and cutting-edge technology to improve patient outcomes.

    Dr Odei's research interests include optimization of genitourinary cancer treatments, understanding the role of radiotherapy and hormone therapy in recurrent or metastatic prostate cancer, incorporating biomarker use for prognostication and predictive evaluation in prostate/bladder cancers, and the utilization of artificial intelligence for synthesizing molecular signatures to inform clinic management decisions. His non-cancer related research work focuses on equity in the academic workforce and health equity.

    Dr Odei's work has been published in premier medical journals such as JAMA Internal Medicine, JAMA Network Open, and International Journal of Radiation Oncology, Biology, and Physics. He has presented his research at international conferences such as the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), and National Medical Association (NMA). Some of his research work has scored in the top 5% of all research outputs scored by Altmetric.

    He is the recent recipient of the 2023 University of Utah GUCC Pilot Grant for prostate cancer research, and the highly-competitive Robert A. Winn Diversity in Clinical Trials: Career Development Award, supported by the Bristol Myers Squibb Foundation.

    Outside of work he enjoys spending time with his wife and daughters, playing chess, and volunteers in religious and community events.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Primary

    Education history

    Residency Radiation Oncology - Ohio State University College of Medicine Resident
    University of North Dakota School of Medicine & Health Sciences Transitional Internship
    Certification Clinical Research - David Geffen School of Medicine at UCLA Certificate
    Medicine - David Geffen School of Medicine at UCLA M.D.
    Undergraduate Chemical Engineering - Brigham Young University B.S.

    Selected Publications

    Journal Article

    1. Odei BC, Herrera S, Huang C, Griffith KA, Bae J, Lastra AZ, Jagsi R (2024). Portrayal of Women as Physicians in Movies, 1990-2020. JAMA Intern Med, 183(10), 1168-1170. (Read full article)
    2. Odei BC, Pan X, Bello-Pardo E, Mitchell D, Thomas CR Jr, Diaz DA (2022). Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists. Am J Clin Oncol, 45(3), 112-115. (Read full article)
    3. Odei BC, Seldon C, Fernandez M, Rooney MK, Bae J, Acheampong J, Ahmed A (2021). Representation of Women in the Leadership Structure of the US Health Care System. JAMA Netw Open, 4(11), e2136358. (Read full article)
    4. Odei BC, Chino F, Mitchell D (2021). A Charge to Academic Chairs-Reply. JAMA Intern Med, 181(8), 1136-1137. (Read full article)
    5. Odei B, Kahn J, Holliday EB, Diaz DA, Bello-Pardo E, Odei J, Bae J, Arnett A, Raval R, Mitchell D (2021). Where Are the Women in Radiation Oncology? A Cross-Sectional Multi-Specialty Comparative Analysis. Adv Radiat Oncol, 6(5), 100735. (Read full article)
    6. Odei BC, Jagsi R, Diaz DA, Addison D, Arnett A, Odei JB, Mitchell D (2021). Evaluation of Equitable Racial and Ethnic Representation Among Departmental Chairs in Academic Medicine, 1980-2019. JAMA Netw Open, 4(5), e2110726. (Read full article)
    7. Odei BC, Gawu P, Bae S, Fabian D, Odei J, Lee C, Mitchell D (2020). Evaluation of Progress Toward Gender Equity Among Departmental Chairs in Academic Medicine. JAMA Intern Med, 181(4), 548-550. (Read full article)
    8. Xiao H, Odei B, Clinton S, Mitchell D (2021). The potential role of DEK over-expression in the radiation response of head and neck cancer. Radiat Med Prot.
    9. Odei B, Holliday EB, Jagsi R, Chino F, Schulmire C, Kudrimoti M, Chen AM, Raval R, Fabian D (2020). Recruitment Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match. Int J Radiat Oncol Biol Phys, 109(2), 637-638. (Read full article)
    10. Odei B, Quick A (2020). The implications of COVID-19 in radiation oncology in the United States. Curr Oncol, 27(5), 279-280. (Read full article)
    11. Odei B, Das P, Pinnix C, Raval R, Holliday EB (2020). Potential Implications of the New USMLE Step 1 Pass/Fail Format for Diversity Within Radiation Oncology. Adv Radiat Oncol, 6(1), 100524. (Read full article)
    12. Odei B, Rwigema JC, Eilber FR, Eilber FC, Selch M, Singh A, Chmielowski B, Nelson SD, Wang PC, Steinberg M, Kamrava M (2017). Predictors of Local Recurrence in Patients With Myxofibrosarcoma. Am J Clin Oncol, 41(9), 827-831. (Read full article)
    13. Odei B, Boothe D, Suneja G, Werner TL, Gaffney DK (2017). Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. Am J Clin Oncol, 41(8), 784-791. (Read full article)
    14. Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney DK (2017). The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk, 17(12), 819-824. (Read full article)
    15. Boothe D, Williams N, Odei B, Poppe MM, Werner TL, Suneja G, Gaffney DK (2017). The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care. Int J Gynecol Cancer, 27(5), 912-922. (Read full article)
    16. Odei B, Frandsen JE, Boothe D, Ermoian RP, Poppe MM (2016). Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Int J Radiat Oncol Biol Phys, 97(1), 60-63.
    17. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, L Werner T, Gaffney DK (2016). Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427]. Gynecol Oncol, 143(3), 690-691. (Read full article)
    18. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney DK (2016). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival. Gynecol Oncol, 141(3), 421-427. (Read full article)
    19. Odei BC, Boothe D, Lloyd S, Gaffney DK (2016). A comprehensive analysis of brachytherapy clinical trials over the past 15 years. Brachytherapy, 15(6), 679-686. (Read full article)

    Review

    1. Anaba U, Ishola A, Alabre A, Bui A, Prince M, Okafor H, Kola-Kehinde O, Joseph JJ, Mitchell D, Odei BC, Uzendu A, Williams KP, Capers Q 4th, Addison D (2021). Diversity in modern heart failure trials: Where are we, and where are we going. [Review]. Int J Cardiol, 348, 95-101. (Read full article)

    Commentary

    1. Odei BC, Mitchell D (2023). The Asian Glass Ceiling in Academic Medical Leadership. Int J Radiat Oncol Biol Phys, 116(2), 213. (Read full article)

    Editorial

    1. Hutten RJ, Odei B, Rivera A, Suneja G (2022). Achieving Health Equity in Radiation Oncology-Moving From Awareness to Action. Int J Radiat Oncol Biol Phys, 114(2), 195-197. (Read full article)
    2. Odei BCL, Boothe D, Keole SR, Vargas CE, Foote RL, Schild SE, Ashman JB (2017). A 20-Year Analysis of Clinical Trials Involving Proton Beam Therapy. Int J Part Ther, 3(3), 398-406. (Read full article)

    Letter

    1. Odei BC, Bae J, Littman D, Lastra AZ, Morgan A, Agabalogun T, Herrera S, Odei J, Fabian D, Chino F (2021). Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match. [Letter to the editor]. Int J Radiat Oncol Biol Phys, 110(3), 919-921. (Read full article)
    2. Odei B, Bae S, Diaz DA (2020). Challenges influencing the utilization of prostate brachytherapy in the United States. [Letter to the editor]. Radiother Oncol, 154, 123-124. (Read full article)
  • News & Podcasts